Par Drugs And Chemicals Ltd - Stock Valuation and Financial Performance

BSE: 0 | NSE: PAR | Chemicals | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Par Drugs & Chem.

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Undervalued

3. Price Trend

Par Drugs And Chemicals stock performance -

mw4me loader
P/E Ratio (SA):
14.09
Market Cap:
257.4 Cr.
52-wk low:
0
52-wk high:
0

Is Par Drugs And Chemicals Ltd an attractive stock to invest in?

1. Is Par Drugs And Chemicals Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Par Drugs And Chemicals Ltd is a good quality company.

2. Is Par Drugs And Chemicals Ltd undervalued or overvalued?

The key valuation ratios of Par Drugs And Chemicals Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

3. Is Par Drugs And Chemicals Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Par Drugs And Chemicals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Par Drugs & Chem.:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Par Drugs And Chemicals Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 9.9%9.4%12.3%11.2%12.4%15.6%28.7%21.9%23.2%25%-
Value Creation
Index
-0.3-0.3-0.1-0.2-0.10.11.10.60.70.8-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 33.333.348.842.446.355.960.875.195.895.6104
Sales YoY Gr.-0%46.6%-13.1%9.3%20.6%8.8%23.6%27.6%-0.1%-
Adj EPS 1.60.83.42.82.83.98.37.59.111.814.9
YoY Gr.--52.4%337.2%-17.3%-0.4%37%115.8%-9.9%21.8%29.2%-
BVPS (₹) 20.921.524.928.232.43342.448.757.969.678.6
Adj Net
Profit
0.90.41.81.52.54.710.29.211.214.518
Cash Flow from Ops. 8.96.59.24.73.47.712.17.613.420.3-
Debt/CF from Ops. 3.74.72.753.50.80.7000-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 12.5%15.6%16.3%-0.1%
Adj EPS 24.5%33.2%12.3%29.2%
BVPS14.3%16.5%17.9%20.2%
Share Price - 36% 3.9% -3.4%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
5.32.510.17.610.113.62216.417.118.520
Op. Profit
Mgn %
22.521.617.418.917.716.926.421.71923.925.9
Net Profit
Mgn %
2.71.33.83.65.48.516.812.311.715.217.6
Debt to
Equity
1.91.81.31.10.40.20.20000
Working Cap
Days
14915310811010293101105948891
Cash Conv.
Cycle
4751332942383032343568

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 20.00%

Sales growth is growing at healthy rate in last 3 years 16.33%

Net Profit is growing at healthy rate in last 3 years 12.33%

Sales growth is not so good in last 4 quarters at 7.58%

Latest Financials - Par Drugs And Chemicals Ltd.

Standalone Consolidated
TTM EPS (₹) 14.9 -
TTM Sales (₹ Cr.) 104 -
BVPS (₹.) 78.6 -
Reserves (₹ Cr.) 84 -
P/BV 2.66 -
PE 14.09 -
From the Market
52 Week Low / High (₹) 0.00 / 0.00
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 257
Equity (₹ Cr.) 12.3
Face Value (₹) 10
Industry PE 57.2

Management X-Ray of Par Drugs & Chem.:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Par Drugs & Chem.

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales33334942465661759696
Operating Expenses 26264034384645597873
Manufacturing Costs881210121414182322
Material Costs13132118192422294034
Employee Cost 1222233334
Other Costs 335556791113
Operating Profit 77888916161823
Operating Profit Margin (%) 22.5%21.6%17.4%18.9%17.7%16.9%26.4%21.7%19.0%23.9%
Other Income 0000000000
Interest 4432211000
Depreciation 2333333333
Exceptional Items 0000002000
Profit Before Tax 11333615131520
Tax 0111113345
Profit After Tax 1022351291115
PAT Margin (%) 2.7%1.3%3.8%3.6%5.4%8.5%19.1%12.3%11.8%15.2%
Adjusted EPS (₹)1.60.83.42.82.83.99.47.59.211.8
Dividend Payout Ratio (%)0%0%0%0%0%32%0%17%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 17171921294152607186
Share Capital 8888466121212
Reserves 991113253446485973
Minority Interest0000000000
Debt282621181058000
Long Term Debt21161413654000
Short Term Debt71075403000
Trade Payables76855671185
Others Liabilities 78810791081011
Total Liabilities 595856545160767989102

Fixed Assets

Gross Block54545656575753606874
Accumulated Depreciation9121417202323262933
Net Fixed Assets45434239363430343841
CWIP 0000015000
Investments 0000000000
Inventories4644433554
Trade Receivables878991212181714
Cash Equivalents 01000721162237
Others Assets2122225566
Total Assets 595856545160767989102

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 9795381281320
PBT 11333615131520
Adjustment 6655431333
Changes in Working Capital 2-11-3-4-1-0-5-02
Tax Paid 00-10-1-1-4-3-4-4
Cash Flow From Investing Activity 00-2-10-10-3-7-6
Capex 00-2-10-20-3-7-6
Net Investments 0000000000
Others 0000000000
Cash Flow From Financing Activity -9-5-8-4-312-1000
Net Proceeds from Shares 0000690000
Net Proceeds from Borrowing 0-5-2-1-7-10-400
Interest Paid -4-4-2-2-2-1-1000
Dividend Paid 00000-1-1-200
Others -53-3-1-1-43-300
Net Cash Flow -11-100714-5614
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)8.183.6914.7510.6311.3513.6825.0216.4417.2918.49
ROCE (%)9.929.3612.3411.1912.4115.5628.6821.8523.225.02
Asset Turnover Ratio0.550.570.860.881.011.141.011.091.291.13
PAT to CFO Conversion(x)9N/A4.52.511.610.891.181.33
Working Capital Days
Receivable Days84825863596066676052
Inventory Days41523630292116171716
Payable Days15718412313397861081108573

Par Drugs And Chemicals Ltd Stock News

Par Drugs And Chemicals Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Par Drugs & Chem. on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Par Drugs & Chem. stood at ₹257.4.
The latest P/E ratio of Par Drugs & Chem. as of 01-Jan-1970 05:30 is 14.09.
The latest P/B ratio of Par Drugs & Chem. as of 01-Jan-1970 05:30 is 2.66.
The 52-week high of Par Drugs & Chem. is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Par Drugs & Chem. is ₹104.1 ( Cr.) .

About Par Drugs And Chemicals Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.